Insulet (PODD) Other financing activities (2010 - 2026)
Insulet's (PODD) quarterly Other financing activities came in at $100000.0 in Q2 2026, down 99.01% on a YoY basis from $10.1 million in Q2 2025, and down 75.0% quarter-over-quarter from $400000.0 in Q1 2026.
Analysis
Insulet (PODD) Other financing activities (2010 - 2026) Analysis & Trends
Insulet (PODD) has reported Other financing activities for 9 consecutive years, with $100000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other financing activities fell 99.01% year-over-year to $100000.0; the trailing twelve-month figure through Jun 2026 stood at $6.9 million (down 50.36% YoY), and the FY2025 full-year result was $19.0 million, up 131.71% from the prior year.
- Other financing activities fell to $100000.0 in Q2 2026 per PODD's latest filing, from $400000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $10.1 million in Q2 2025 and bottomed at $100000.0 in Q3 2023.
- Historically, Other financing activities has averaged $2.8 million across 5 years, with a median of $2.1 million in 2022.
- The sharpest annual moves came in 2025 and 2026: Other financing activities jumped 818.18% in 2025, then slumped 99.01% in 2026.
- Over 5 years, Other financing activities stood at $2.6 million in 2022, then soared by 50.0% to $3.9 million in 2023, then tumbled by 87.18% to $500000.0 in 2024, then jumped by 260.0% to $1.8 million in 2025, then tumbled by 94.44% to $100000.0 in 2026.
- According to Business Quant data, Other financing activities over the past three periods registered $100000.0, $400000.0, and $1.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.52 Bn | 122.30 Bn | 1.96 Bn |
| 3 | Medtronic | 117.07 Bn | 108.26 Bn | 6.34 Bn |
| 4 | Stryker | 103.72 Bn | 100.25 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.45 Bn | 1.35 Bn |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn |
| 10 | Insulet | 9.31 Bn | 8.77 Bn | 562.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 100,000.00 |
| Mar 31, 2026 | 400,000.00 |
| Dec 31, 2025 | 1.80 Mn |
| Sep 30, 2025 | 4.60 Mn |
| Jun 30, 2025 | 10.10 Mn |
| Mar 31, 2025 | 2.50 Mn |
| Dec 31, 2024 | 500,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 5.80 Mn |
| Dec 31, 2023 | 3.90 Mn |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 6.30 Mn |
| Mar 31, 2023 | 6.00 Mn |
| Dec 31, 2022 | 2.60 Mn |
| Sep 30, 2022 | 2.40 Mn |
| Jun 30, 2022 | 800,000.00 |
| Mar 31, 2022 | 1.10 Mn |
| Dec 31, 2021 | 4.90 Mn |
| Sep 30, 2021 | 4.30 Mn |